ADIL
Adial Pharmaceuticals
ADIL
ADIL
About: Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
Employees: 7
0
Funds
holding %
of 7,463 funds
–
Analysts
bullish %
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
23% more funds holding
Funds holding: 13 [Q1] → 16 (+3) [Q2]
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
1.37% less ownership
Funds ownership: 3.62% [Q1] → 2.25% (-1.37%) [Q2]
54% less capital invested
Capital invested by funds: $151K [Q1] → $70.2K (-$81.2K) [Q2]
Financial journalist opinion
Charts implemented using
Lightweight Charts™